Extraordinary Board agenda and papers 18 and 19 February 2026

Please click here to view the livestream of the Extraordinary Hywel Dda UHB Board Meeting at 9.30am on 19.02.26 - use this link to view the stream in Welsh (when presentations are made in Welsh) 

Please click here to view the livestream of the Extraordinary Hywel Dda UHB Board Meeting at 9.30am on 19.02.26 - use this link to view the stream in English and/or BSL

Please click here to view the recording of the Extraordinary Hywel Dda UHB Board Meeting on 18.02.26 - use this link to view the stream in Welsh (when presentations are made in Welsh) 

Please click here to view the recording of the Extraordinary Hywel Dda UHB Board Meeting on 18.02.26 - use this link to view the stream in English and/or BSL

Agenda Extraordinary Public Board Meeting 18 and 19 February 2026 - Bilingual (PDF, 155KB, 11 February 2026, opens in new tab)

1. Introduction and Apologies 

1.1 Welcome and apologies [Presenter: Neil Wooding]

1.2 Declaration of Interests [Presenters: All]

2. Clinical Services Plan Background and Public Consultation Findings  [Presenter: Lee Davies]

For approval

Clinical Services Plan Background and Public Consultation Findings SBAR (PDF, 210KB, 11 February 2026, opens in new tab)

 Informing Plan (PDF, 3.9MB, 5 February 2026, opens in new tab)

Correspondence from Llais

Clinical Services Plan Board Briefing Plan

Appendices

Health Impact Assessments (PDF, 6.5MB, 5 February 2026, opens in new tab)

Quality Impact Assessments (PDF, 5MB, 5 February 2026, opens in new tab)

CSP Regional Impact Assessment SBUHB Phase 3 update (PDF, 486KB, 5 February 2026, opens in new tab)

CSP Regional Impact Assessment MWJC Phase 3 update (PDF, 927KB, 5 February 2026, opens in new tab)

Environmental and Sustainability Impact Assessments (PDF, 5MB, 5 February 2026, opens in new tab)

Hywel Dda University Health Board Clinical Services Plan Consultation Report (PDF, 5.6MB, 22 January 2026, opens in new tab)

Phase 3 - Closing Report - Clinical Services Plan (PDF, 958KB, 5 February 2026, opens in new tab)

Assurance letters final (PDF, 711KB, 5 February 2026, opens in new tab)

Miscellaneous

HICO Advice Note Consideration of optimism bias in the consultation report (PDF, 317KB, 5 February 2026, opens in new tab)

 CSP Alternative options (PDF, 1.2MB, 5 February 2026, opens in new tab)

 Phase 3 SWOT Analysis (PDF, 687KB, 5 February 2026, opens in new tab)

Break

3. Acute Services  [Presenter: Lee Davies]

For discussion

• Emergency General Surgery
• Critical Care
• Stroke

Lunch break

4. Planned Care Services [Presenter: Lee Davies]

For discussion

• Orthopaedics
• Ophthalmology
• Dermatology
• Urology

Break

5. Diagnostic Services  [Presenter: Lee Davies]

For discussion

• Radiology
• Endoscopy

6. Role of Acute Hospital Sites  [Presenter: Lee Davies]

For discussion

In Committee Session

Motion to exclude the public from the meeting in accordance with the provisions of section 1 (2) and (3) of the Public Bodies (Admissions to Meetings) Act 1960.

Representatives of the press and other members of the public are excluded from the second part of the meeting on the grounds that it would be prejudicial to the public interest due to the confidential nature of the business transacted.  This section of the meeting will be held in private session

In Committee Agenda:-

• Regional Cellular Pathology Transitional Memorandum of Understanding
• Regional Cellular Pathology Preferred Laboratory Site

Thursday 19 February 2026

7. Clinical Services Plan Decision-Making  [Presenter: Neil Wooding]

  7.1 Acute Services   [Presenter: Lee Davies]

  For approval

• Emergency General Surgery
• Critical Care
• Stroke

  7.2 Planned Care Services   [Presenter: Lee Davies]

   For approval

• Orthopaedics
• Ophthalmology
• Dermatology
• Urology

   7.3 Diagnostic Services   [Presenter: Lee Davies]

   For approval

• Radiology
• Endoscopy

   7.4 Role of Acute Hospital Sites   [Presenter: Lee Davies]

Break

8. Regional Cellular Pathology     [Presenters: Andrew Carruthers/ Lee Davies] 

For approval

  8.1 Regional Cellular Pathology Transitional Memorandum of Understanding 

  8.2 Regional Cellular Pathology Preferred Laboratory Site 

  [Presenters: Andrew Carruthers/ Lee Davies]

9. Any other Business

10. Date and time of next meeting

  Thursday 26 March 2026